Lower serum serotonin is associated with greater cardiovascular risk burden and poorer cognitive outcomes in mild cognitive impairment and amyloid-positive participants.
Neuroscience · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansFemaleMaleSerotoninCognitive DysfunctionAgedCross-Sectional StudiesAlzheimer DiseaseAmyloid beta-PeptidesCardiovascular DiseasesNeuropsychological TestsHeart Disease Risk FactorsMiddle AgedAged, 80 and overRisk FactorsAlzheimer’s diseaseCardiovascular riskCognitive functionsVascular dementia
Come citare questo studio
Nahlah Fahad Alreshidi, Saeed A Al-Qahtani, Kholoud S Almasoudi, Iman M Mirza, Mohanad M Abdulhag, Aseel Awad Alsaidan, Jawaher Bin Jumah, Alzheimer’s Disease Neuroimaging Initiative. (2026). Lower serum serotonin is associated with greater cardiovascular risk burden and poorer cognitive outcomes in mild cognitive impairment and amyloid-positive participants.. Neuroscience. DOI: 10.1016/j.neuroscience.2026.09.005
Consulta la pubblicazione originale ↗